Pharmacology Translational Sciences ConsultantSCYNEXIS, Inc.Jersey City, New Jersey, United States
Disclosure(s): SCYNEXIS, Inc.: Advisor/Consultant
94 - Efficacy of SCY-247, a Second-generation Triterpenoid Antifungal, in Three Murine Models of Invasive Fungal Infections
Thursday, October 17, 202410:45 AM – 11:00 AM US PT